| Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 (AGAP-2) (Centaurin-gamma-1) (Cnt-g1) (GTP-binding and GTPase-activating protein 2) (GGAP2) (Phosphatidylinositol 3-kinase enhancer) (PIKE) | AGAP2 CENTG1 KIAA0167 | Q99490 | 3 |
| Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 | AGAP3 | E9PAL8 | 3 |
| Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 (AGAP-3) (CRAM-associated GTPase) (CRAG) (Centaurin-gamma-3) (Cnt-g3) (MR1-interacting protein) (MRIP-1) | AGAP3 CENTG3 | Q96P47 | 3 |
| Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2) (Cnt-d2) | ARAP1 CENTD2 KIAA0782 | Q96P48 | 3 |
| Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 (Development and differentiation-enhancing factor-like 1) (Protein up-regulated in liver cancer 1) | ASAP3 DDEFL1 UPLC1 | Q8TDY4 | 3 |
| Arginine decarboxylase (ADC) (ARGDC) (EC 4.1.1.19) (ODC-paralogue) (ODC-p) (Ornithine decarboxylase-like protein) | ADC KIAA1945 ODCP | Q96A70 | 3 |
| ARHGAP27 protein (Fragment) | ARHGAP27 | Q8N2Y9 | 3 |
| Armadillo repeat-containing protein 1 | ARMC1 ARCP | Q9NVT9 | 3 |
| Aryl hydrocarbon receptor nuclear translocator (ARNT protein) (Class E basic helix-loop-helix protein 2) (bHLHe2) (Dioxin receptor, nuclear translocator) (Hypoxia-inducible factor 1-beta) (HIF-1-beta) (HIF1-beta) | ARNT BHLHE2 | P27540 | 3 |
| Arylsulfatase D (ASD) (EC 3.1.6.-) | ARSD | P51689 | 3 |
| Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2) | ASGR2 CLEC4H2 | P07307 | 3 |
| Aspartate--tRNA ligase, mitochondrial (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) | DARS2 | Q6PI48 | 3 |
| Aspartoacylase-2 (EC 3.5.1.-) (Acylase III) (Aminoacylase-3) (ACY-3) (Hepatitis C virus core-binding protein 1) (HCBP1) (HCV core-binding protein 1) | ACY3 ASPA2 | Q96HD9 | 3 |
| AT-rich interactive domain-containing protein 3A (ARID domain-containing protein 3A) (B-cell regulator of IgH transcription) (Bright) (Dead ringer-like protein 1) (E2F-binding protein 1) | ARID3A DRIL1 DRIL3 DRX E2FBP1 | Q99856 | 3 |
| AT-rich interactive domain-containing protein 3B (ARID domain-containing protein 3B) (Bright and dead ringer protein) (Bright-like protein) | ARID3B BDP DRIL2 | Q8IVW6 | 3 |
| Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein) | ATXN10 SCA10 | Q9UBB4 | 3 |
| ATP synthase subunit a (F-ATPase protein 6) | MT-ATP6 ATP6 ATPASE6 MTATP6 | P00846 | 3 |
| ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) | ABCA1 ABC1 CERP | O95477 | 3 |
| ATP-binding cassette sub-family A member 7 (ABCA-SSN) (Autoantigen SS-N) (Macrophage ABC transporter) | ABCA7 | Q8IZY2 | 3 |
| ATP-binding cassette sub-family A member 9 | ABCA9 | Q8IUA7 | 3 |
| ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) | ABCC8 HRINS SUR SUR1 | Q09428 | 3 |
| ATP-binding cassette sub-family G member 1 (ATP-binding cassette transporter 8) (White protein homolog) | ABCG1 ABC8 WHT1 | P45844 | 3 |
| ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) | CARKD | Q8IW45 | 3 |
| ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (IRK-2) (Inward rectifier K(+) channel Kir2.2v) (Potassium channel, inwardly rectifying subfamily J member 12) | KCNJ12 IRK2 KCNJN1 | Q14500 | 3 |
| ATPase SWSAP1 (SWIM-type zinc finger 7-associated protein 1) (SWS1-associated protein 1) (ZSWIM7-associated protein 1) (ZSWIM7AP1) | SWSAP1 C19orf39 | Q6NVH7 | 3 |
| Autism susceptibility gene 2 protein | AUTS2 KIAA0442 | Q8WXX7 | 3 |
| B box and SPRY domain-containing protein | BSPRY | Q5W0U4 | 3 |
| B-cell CLL/lymphoma 7 protein family member A | BCL7A | Q4VC05 | 3 |
| B-cell CLL/lymphoma 9 protein (B-cell lymphoma 9 protein) (Bcl-9) (Protein legless homolog) | BCL9 | O00512 | 3 |
| B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10) (Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein) (hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator) (CIPER) (Cellular homolog of vCARMEN) (cCARMEN) (Cellular-E10) (c-E10) (Mammalian CARD-containing adapter molecule E10) (mE10) | BCL10 CIPER CLAP | O95999 | 3 |
| B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856) | BCL11A CTIP1 EVI9 KIAA1809 ZNF856 | Q9H165 | 3 |
| B-cell translocation gene 1, anti-proliferative (B-cell translocation gene 1, anti-proliferative, isoform CRA_b) (BTG1) (BTG1 protein) (cDNA, FLJ93822, Homo sapiens B-cell translocation gene 1, anti-proliferative(BTG1), mRNA) | BTG1 hCG_21188 | Q6IBC8 | 3 |
| B1 bradykinin receptor (B1R) (BK-1 receptor) | BDKRB1 BRADYB1 | P46663 | 3 |
| B9 domain-containing protein 2 (MKS1-related protein 2) | B9D2 MKSR2 | Q9BPU9 | 3 |
| Band 4.1-like protein 5 | EPB41L5 KIAA1548 | Q9HCM4 | 3 |
| Bardet-Biedl syndrome 7 protein (BBS2-like protein 1) | BBS7 BBS2L1 | Q8IWZ6 | 3 |
| BarH-like 2 homeobox protein | BARHL2 | Q9NY43 | 3 |
| Basic helix-loop-helix domain-containing protein KIAA2018 | KIAA2018 | Q68DE3 | 3 |
| Basic immunoglobulin-like variable motif-containing protein | BIVM | Q86UB2 | 3 |
| Bcl-2-modifying factor | BMF | Q96LC9 | 3 |
| Bcl-2-related ovarian killer protein (hBOK) (Bcl-2-like protein 9) (Bcl2-L-9) | BOK BCL2L9 | Q9UMX3 | 3 |
| Beta 5-tubulin (Beta-tubulin protein) (Tubulin, beta) (Tubulin, beta, isoform CRA_a) | TUBB OK/SW-cl.56 hCG_26016 | Q5SU16 | 3 |
| Beta-1,4-galactosyltransferase 2 (Beta-1,4-GalTase 2) (Beta4Gal-T2) (b4Gal-T2) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2) [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] | B4GALT2 | O60909 | 3 |
| Beta-1,4-galactosyltransferase 4 (Beta-1,4-GalTase 4) (Beta4Gal-T4) (b4Gal-T4) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4) [Includes: N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Lactotriaosylceramide beta-1,4-galactosyltransferase (EC 2.4.1.275) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase)] | B4GALT4 UNQ552/PRO1109 | O60513 | 3 |
| Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) [Includes: Xylosylprotein 4-beta-galactosyltransferase (EC 2.4.1.133) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein beta-1,4-galactosyltransferase)] | B4GALT7 XGALT1 UNQ748/PRO1478 | Q9UBV7 | 3 |
| Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) (Testis development protein NYD-SP19) | CTNNBL1 C20orf33 PP8304 | Q8WYA6 | 3 |
| Beta-crystallin B2 | CRYBB2 | R4UMM2 | 3 |
| Beta-defensin 1 (BD-1) (hBD-1) (Defensin, beta 1) | DEFB1 BD1 HBD1 | P60022 | 3 |
| Beta-defensin 4A (Beta-defensin 2) (BD-2) (hBD-2) (Defensin, beta 2) (Skin-antimicrobial peptide 1) (SAP1) | DEFB4A DEFB102 DEFB2 DEFB4; DEFB4B | O15263 | 3 |
| Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase) | ENO3 | P13929 | 3 |
| Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha) | HEXA | P06865 | 3 |
| Beta-parvin (Affixin) | PARVB CGI-56 | Q9HBI1 | 3 |
| Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5) | BHMT | Q93088 | 3 |
| Biogenesis of lysosome-related organelles complex 1 subunit 3 (BLOC-1 subunit 3) | BLOC1S3 BLOS3 | Q6QNY0 | 3 |
| Biogenesis of lysosome-related organelles complex 1 subunit 5 (BLOC-1 subunit 5) (Protein Muted homolog) | BLOC1S5 MUTED | Q8TDH9 | 3 |
| Biogenesis of lysosome-related organelles complex 1 subunit 6 (BLOC-1 subunit 6) (Pallid protein homolog) (Pallidin) (Syntaxin 13-interacting protein) | BLOC1S6 PA PLDN | Q9UL45 | 3 |
| Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) | BLM RECQ2 RECQL3 | P54132 | 3 |
| Bone morphogenetic protein 15 (BMP-15) (Growth/differentiation factor 9B) (GDF-9B) | BMP15 GDF9B | O95972 | 3 |
| Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate) | BAIAP2L1 IRTKS | Q9UHR4 | 3 |
| Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39) | BCAT1 BCT1 ECA39 | P54687 | 3 |
| Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein) | BRCA2 FACD FANCD1 | P51587 | 3 |
| Bromodomain and PHD finger-containing protein 3 | BRPF3 KIAA1286 | Q9ULD4 | 3 |
| BTB/POZ domain-containing protein 10 | BTBD10 | Q9BSF8 | 3 |
| BTB/POZ domain-containing protein 7 | BTBD7 KIAA1525 | Q9P203 | 3 |
| BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain) | KCTD12 C13orf2 KIAA1778 PFET1 | Q96CX2 | 3 |
| BTB/POZ domain-containing protein KCTD17 | KCTD17 | Q8N5Z5 | 3 |
| BTB/POZ domain-containing protein KCTD9 | KCTD9 | Q7L273 | 3 |
| Butyrophilin subfamily 1 member A1 (BT) | BTN1A1 BTN | Q13410 | 3 |
| C-C chemokine receptor type 1 (C-C CKR-1) (CC-CKR-1) (CCR-1) (CCR1) (HM145) (LD78 receptor) (Macrophage inflammatory protein 1-alpha receptor) (MIP-1alpha-R) (RANTES-R) (CD antigen CD191) | CCR1 CMKBR1 CMKR1 SCYAR1 | P32246 | 3 |
| C-C chemokine receptor type 5 (C-C motif chemokine receptor 5 A159A variant) (C-C motif chemokine receptor 5 I124I variant) (C-C motif chemokine receptor 5 I237I variant) (Chemokine (C-C motif) receptor 5, isoform CRA_a) (cDNA FLJ78003, highly similar to Homo sapiens chemokine (C-C motif) receptor 5, mRNA) | CCR5 hCG_15321 | Q38L21 | 3 |
| C-C motif chemokine 22 (CC chemokine STCP-1) (MDC(1-69)) (Macrophage-derived chemokine) (Small-inducible cytokine A22) (Stimulated T-cell chemotactic protein 1) [Cleaved into: MDC(3-69); MDC(5-69); MDC(7-69)] | CCL22 MDC SCYA22 A-152E5.1 | O00626 | 3 |
| C-myc promoter-binding protein (DENN domain-containing protein 4A) | DENND4A IRLB MYCPBP | Q7Z401 | 3 |
| C-X-C motif chemokine 6 (Chemokine alpha 3) (CKA-3) (Granulocyte chemotactic protein 2) (GCP-2) (Small-inducible cytokine B6) [Cleaved into: Small-inducible cytokine B6, N-processed variant 1; Small-inducible cytokine B6, N-processed variant 2; Small-inducible cytokine B6, N-processed variant 3] | CXCL6 GCP2 SCYB6 | P80162 | 3 |
| C2 domain-containing protein 2-like (Transmembrane protein 24) | C2CD2L KIAA0285 TMEM24 DLNB23 | O14523 | 3 |
| C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa) | C2CD5 CDP138 KIAA0528 | Q86YS7 | 3 |
| C5a anaphylatoxin chemotactic receptor 2 (Complement component 5a receptor 2) (G-protein coupled receptor 77) | C5AR2 C5L2 GPR77 | Q9P296 | 3 |
| C7 protein (Fragment) | C7 | Q05CI3 | 3 |
| CAAX prenyl protease 2 (EC 3.4.22.-) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) (hRCE1) | RCE1 FACE2 RCE1A RCE1B | Q9Y256 | 3 |
| Cadherin-16 (Kidney-specific cadherin) (Ksp-cadherin) | CDH16 UNQ695/PRO1340 | O75309 | 3 |
| Cadherin-23 (Otocadherin) | CDH23 KIAA1774 KIAA1812 UNQ1894/PRO4340 | Q9H251 | 3 |
| Cadherin-like protein 26 (Cadherin-like protein VR20) | CDH26 | Q8IXH8 | 3 |
| Calcitonin [Cleaved into: Calcitonin; Katacalcin (Calcitonin carboxyl-terminal peptide) (CCP) (PDN-21)] | CALCA CALC1 | P01258 | 3 |
| Calcium binding protein 39, isoform CRA_a (cDNA FLJ78295, highly similar to Homo sapiens calcium binding protein 39 (CAB39), mRNA) (cDNA, FLJ96790, Homo sapiens MO25 protein (MO25), mRNA) | CAB39 hCG_34334 | A8K8L7 | 3 |
| Calcium homeostasis modulator protein 2 (Protein FAM26B) | CALHM2 FAM26B | Q9HA72 | 3 |
| Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A) | ORAI1 CRACM1 TMEM142A | Q96D31 | 3 |
| Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo) | KCNMA1 KCNMA SLO | Q12791 | 3 |
| Calcium-binding and coiled-coil domain-containing protein 1 (Calphoglin) (Coiled-coil coactivator protein) (Sarcoma antigen NY-SAR-3) | CALCOCO1 KIAA1536 PP13275 UNQ2436/PRO4996 | Q9P1Z2 | 3 |
| Calcium-binding and coiled-coil domain-containing protein 2 (Antigen nuclear dot 52 kDa protein) (Nuclear domain 10 protein NDP52) (Nuclear domain 10 protein 52) (Nuclear dot protein 52) | CALCOCO2 NDP52 | Q13137 | 3 |
| Calcium-binding mitochondrial carrier protein SCaMC-1 (Mitochondrial ATP-Mg/Pi carrier protein 1) (Mitochondrial Ca(2+)-dependent solute carrier protein 1) (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) | SLC25A24 APC1 MCSC1 SCAMC1 | Q6NUK1 | 3 |
| Calcium-binding protein 39 (MO25alpha) (Protein Mo25) | CAB39 MO25 CGI-66 | Q9Y376 | 3 |
| Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta) | CAMKK2 CAMKKB KIAA0787 | Q96RR4 | 3 |
| Calcium/calmodulin-dependent protein kinase type 1B (EC 2.7.11.17) (CaM kinase I beta) (CaM kinase IB) (CaM-KI beta) (CaMKI-beta) (Pregnancy up-regulated non-ubiquitously-expressed CaM kinase) | PNCK | Q6P2M8 | 3 |
| Calmodulin-like protein 3 (CaM-like protein) (CLP) (Calmodulin-related protein NB-1) | CALML3 | P27482 | 3 |
| Calpain-13 (EC 3.4.22.-) (Calcium-activated neutral proteinase 13) (CANP 13) | CAPN13 | Q6MZZ7 | 3 |
| Calpain-2 catalytic subunit (EC 3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain) | CAPN2 CANPL2 | P17655 | 3 |
| Calpain-7 (EC 3.4.22.-) (PalB homolog) (PalBH) | CAPN7 PALBH | Q9Y6W3 | 3 |
| cAMP-dependent protein kinase inhibitor beta (PKI-beta) | PKIB PRKACN2 | Q9C010 | 3 |
| cAMP-dependent protein kinase type I-beta regulatory subunit | PRKAR1B | P31321 | 3 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.17) (DPDE2) (PDE46) | PDE4A DPDE2 | P27815 | 3 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.17) (DPDE4) (PDE32) | PDE4B DPDE4 | Q07343 | 3 |